RT Journal Article
SR Electronic
T1 Clinical analysis of transcatheter closure of perimembranous ventricular septal defects with occluders made in China
JF Heart
JO Heart
FD BMJ Publishing Group Ltd and British Cardiovascular Society
SP A207
OP A208
DO 10.1136/heartjnl-2011-300867.608
VO 97
IS Suppl 3
A1 Wang xian
A1 Li Xin
A1 Zhao Huaibing
A1 Li Yufeng
A1 Zhang Wei
A1 Li Xiaoming
YR 2011
UL http://heart.bmj.com/content/97/Suppl_3/A207.3.abstract
AB Background Results of perimembranous ventricular septal defects (pmVSD) transcatheter closure have been reported in the literature mostly using a Amplatzer VSD device; However, the data of percutaneous closure of pmVSD with VSD occluder (VSD-O) made in China are still limited. Methods Between February 2005 and June 2009, 78 patients underwent percutaneous closure of pmVSD at our institution. A VSD device made in China was used for all subjects. The Statistic package version 10.0 was used for the statistical computations. Univariate analysis was performed using the χ2 test, Fisher exact. Results A total of eight early complications occurred (10.3%), but in all subjects these were transient. The average follow-up period was 40.5 months. The most significant complication was complete atrioventricular block (cAVB) in the early phase (five subjects,6.4%) and during the follow-up (1 subject,1.3%), which saw no need for pacemaker implantation in six subjects. Cox proportional hazards regression analysis showed that the age was only the variable significantly associated with the occurrence of this complication during the procedure (p=0.025; RR 0.22). Conclusions Percutaneous pmVSD closure used VSD-O made in China is associated with excellent success and closure rates, no mortality, and low morbidity. Currently, pmVSD percutaneous closure is a valuable alternative to surgery. Longer follow-up data and improvements in device characteristics are needed to reduce the risk of cAVB.